Characterization of basigin isoforms and the inhibitory function of basigin-3 in human hepatocellular carcinoma proliferation and invasion

Molecular and Cellular Biology

Volumn 31, Issue 13, 2011, Pages 2591-2604

  Liao, Cheng Gong ^a,c   Kong, Ling Min ^a   Song, Fei ^a   Xing, Jin Liang ^a   Wang, Long Xin ^a   Sun, Zhi Jian ^a   Tang, Hao ^a   Yao, Hui ^a   Zhang, Yang ^a   Wang, Li ^a   Wang, Yu ^b   Yang, Xiang Min ^a   Li, Yu ^a   Chen, Zhi Nan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c LANZHOU GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIGIN 2; BASIGIN 3; BASIGIN 4; ISOPROTEIN; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ARTICLE; CANCER INVASION; CELL INVASION; CELL MEMBRANE; CELL PROLIFERATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD147; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROTEIN ISOFORMS; TISSUE DISTRIBUTION;

EID: 79959457474     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05160-11     Document Type: Article

References (46)

1. Belton, R. J., Jr., L. Chen, F. S. Mesquita, and R. A. Nowak. 2008. Basigin-2 is a cell surface receptor for soluble basigin ligand. J. Biol. Chem. 283:17805- 17814.
2. Biswas, C., et al. 1995. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 55:434-439.
3. Davuluri, R. V., Y. Suzuki, S. Sugano, C. Plass, and T. H. Huang. 2008. The functional consequences of alternative promoter use in mammalian genomes. Trends Genet. 24:167-177.
4. Delaglio, F., et al. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6:277-293.
5. Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161-174.
6. Gabison, E. E., T. Hoang-Xuan, A. Mauviel, and S. Menashi. 2005. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 87:361-368.
7. Guo, H., et al. 1998. Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. Gene 220:99-108.
8. Hanna, S., et al. 2003. A novel form of the membrane protein CD 147 that contains an extra Ig-like domain and interacts homophilically. BMC Biochem. 4:17.
9. Hollstein, M., and P. Hainaut. 2010. Massively regulated genes: the example of TP53. J. Pathol. 220:164-173.
10. Igakura, T., et al. 1998. A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev. Biol. 194:152-165.
11. Jemal, A., et al. 2009. Cancer statistics, 2009. CA Cancer J. Clin. 59:225-249.
12. Jiang, J. L., et al. 2001. The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J. Biol. Chem. 276:46870-46877.
13. Johnson, B., and R. Blevins. 1994. NMR View: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4:603-614.
14. Kanekura, T., X. Chen, and T. Kanzaki. 2002. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int. J. Cancer 99:520-528.
15. Kerppola, T. 2006. Visualization of molecular interactions by fluorescence complementation. Nat. Rev. Mol. Cell Biol. 7:449.
16. Kerppola, T. K. 2006. Complementary methods for studies of protein interactions in living cells. Nat. Methods 3:969-971.
17. Kirk, P., et al. 2000. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 19:3896-3904.
18. Kong, L. M., et al. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma. J. Cell Mol. Med., in press.
19. Kong, L. M., et al. 2010. Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer. Cancer Sci. 101: 1463-1470.
20. Ku, X. M., et al. 2007. Epitope mapping of series of monoclonal antibodies against the hepatocellular carcinoma-associated antigen HAb18G/CD147. Scand. J. Immunol. 65:435-443.
21. Landry, J. R., D. L. Mager, and B. T. Wilhelm. 2003. Complex controls: the role of alternative promoters in mammalian genomes. Trends Genet. 19:640-648.
22. Li, M., Z. Li, D. L. Morris, and L. Rui. 2007. Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling. Endocrinology 148:1615-1621.
23. Li, Y., et al. 2009. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection. Histopathology 54:677-687.
24. Liang, L., T. Major, and T. Bocan. 2002. Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN). Gene 282:75-86.
25. McGlincy, N. J., and C. W. Smith. 2008. Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends Biochem. Sci. 33:385-393.
26. Miyauchi, T., Y. Masuzawa, and T. Muramatsu. 1991. The basigin group of the immunoglobulin superfamily: complete conservation of a segment in and around transmembrane domains of human and mouse basigin and chicken HT7 antigen. J. Biochem. 110:770-774.
27. Pajares, M. J., et al. 2007. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol. 8:349-357.
28. Ponta, H., L. Sherman, and P. A. Herrlich. 2003. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4:33-45.
29. Remy, I., A. Galarneau, and S. W. Michnick. 2002. Detection and visualization of protein interactions with protein fragment complementation assays. Methods Mol. Biol. 185:447-459.
30. Rosenstiel, P., et al. 2006. A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 103:3280-3285.
31. Sattler, M., J. Schleucher, and C. Griesinger. 1999. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog. NMR Spectrosc. 34:93-158.
32. Schlegel, J., et al. 2009. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A. J. Mol. Biol. 391:518-535.
33. Stamm, S., et al. 2005. Function of alternative splicing. Gene 344:1-20.
34. Stetler-Stevenson, W. G., S. Aznavoorian, and L. A. Liotta. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:541-573.
35. Sun, J., and M. E. Hemler. 2001. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res. 61:2276-2281.
36. Tang, W., and M. E. Hemler. 2004. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering. J. Biol. Chem. 279:11112-11118.
37. Toole, B. P. 2003. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr. Top. Dev. Biol. 54:371-389.
38. Winter, C., et al. 2008. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status. Pediatr. Blood Cancer 51:10-16.
39. Wu, S. K., D. K. Ann, K. J. Kim, and V. H. Lee. 2005. Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant. J. Drug Target. 13:521-533.
40. Xu, J., et al. 2007. A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology 45:269-276.
41. Xu, J., et al. 2007. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol. Cancer Res. 5:605-614.
42. Yokoyama, S., C. J. Chen, T. Nguyen, and J. E. Shively. 2007. Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation. Oncogene 26:7637-7646.
43. Yoshida, S., et al. 2000. Homo-oligomer formation by basigin, an immunoglobulin superfamily member, via its N-terminal immunoglobulin domain. Eur. J. Biochem. 267:4372-4380.
44. Yu, X. L., et al. 2008. Crystal structure of HAb18G/CD147: implications for immunoglobulin superfamily homophilic adhesion. J. Biol. Chem. 283: 18056-18065.
45. Yuasa, J., et al. 2001. Specific localization of the basigin protein in human testes from normal adults, normal juveniles, and patients with azoospermia. Andrologia 33:293-299.
46. Zou, M., Y. Guan, H. Ren, F. Zhang, and F. Chen. 2007. Characterization of alternative splicing products of bZIP transcription factors OsABI5. Biochem. Biophys. Res. Commun. 360:307-313.